Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPLA: Intraperitoneal Lidocaine and Bupivacaine in Laparoscopic Abdominal Surgery
NCT07775599Completed
- Sponsor
- Misr University for Science and Technology
- Start
- Aug 2025
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Randomised trial of Lidocaine Hydrochloride Injection, without epinephrine and bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Misr University for Science and Technology. Primary endpoint: Need for rescue opioid analgesia. Started Aug 2025; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrinebupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07775599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07775599.